219 related articles for article (PubMed ID: 10443792)
21. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
[TBL] [Abstract][Full Text] [Related]
22. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection.
Weber B; Berger A; Rabenau H
J Virol Methods; 2001 Aug; 96(2):157-70. PubMed ID: 11445146
[TBL] [Abstract][Full Text] [Related]
24. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
Seo S; Cho Y; Park J
Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
[TBL] [Abstract][Full Text] [Related]
25. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
Carlier P; Harika N; Bailly R; Vranken G
J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
[TBL] [Abstract][Full Text] [Related]
26. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
Chou S; Kim DY; Scott KM; Sewell DL
J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection in a cohort of pregnant women.
El Sanousi SM; Osman ZA; Mohmed AB; Al Awfi MS
Am J Infect Control; 2016 Apr; 44(4):e41-3. PubMed ID: 26810886
[TBL] [Abstract][Full Text] [Related]
29. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
Prince HE; Lapé-Nixon M; Novak-Weekley SM
Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
[TBL] [Abstract][Full Text] [Related]
30. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
[TBL] [Abstract][Full Text] [Related]
31. Trends in Continuity of Pregnancy in Women with Positive Cytomegalovirus IgM during the First Trimester, 2008-2009.
Beloosesky R; Feldblum I; Shrim A; Kertes J; Segal J; Bachar R; Youval Y
Isr Med Assoc J; 2017 Aug; 19(8):484-488. PubMed ID: 28825766
[TBL] [Abstract][Full Text] [Related]
32. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
33. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
34. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus.
Lazzarotto T; Varani S; Spezzacatena P; Gabrielli L; Pradelli P; Guerra B; Landini MP
Viral Immunol; 2000; 13(1):137-41. PubMed ID: 10733175
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis of congenital CMV infection by specific CMV IgM antibody in cord serum with ELISA].
Guo TL; Tang ZY; Wu YX; Yao YJ; Li WR
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):422-5. PubMed ID: 2560989
[TBL] [Abstract][Full Text] [Related]
36. Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines.
Pagnon A; Piras F; Gimenez-Fourage S; Dubayle J; Arnaud-Barbe N; Hessler C; Caillet C
J Clin Virol; 2017 Nov; 96():99-104. PubMed ID: 29035763
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
[TBL] [Abstract][Full Text] [Related]
38. Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus.
van Loon AM; Heessen FW; van der Logt JT; van der Veen J
J Clin Microbiol; 1981 Mar; 13(3):416-22. PubMed ID: 6263941
[TBL] [Abstract][Full Text] [Related]
39. An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions.
Nielsen CM; Hansen K; Andersen HM; Gerstoft J; Vestergaard BF
J Med Virol; 1987 May; 22(1):67-76. PubMed ID: 3035081
[TBL] [Abstract][Full Text] [Related]
40. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
Basson J; Tardy JC; Aymard M
Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
